Spotlight on Julie McElrath

Advancing Toward an HIV Vaccine

Julie McElrath, Director of Vaccine and Infectious Disease Division

As one of the world’s leading HIV vaccine researchers, Julie McElrath has witnessed first-hand the disease’s devastating toll on children and families.

"I thought I had a firm grip on the seriousness of this disease," said McElrath, who has been researching HIV/AIDS and potential vaccines for more than two decades. "But visiting areas in Africa where the epidemic has hit hardest showed me how important our work really is. Parents dying of AIDS is commonplace. Orphans are raised by other orphans. We're experiencing the loss of an entire generation. It is terribly sobering."

As director of the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Division, holder of the Joel D. Meyers Endowed Chair and a leader of a massive international effort to develop a preventive vaccine, McElrath is at the forefront of the AIDS war.

Dr. Julie McElrath
Dr. Julie McElrath, pictured in 2014, focuses on developing an HIV vaccine and the complex relationship between HIV and the immune system. Robert Hood / Fred Hutch

Her lab has identified some of HIV’s key mechanisms and she has led and contributed to a number of national and international HIV prevention efforts. These include the HIV Vaccine Trials Network, which is the world's largest network of its kind, and the Seattle HIV Vaccine Trials Unit.

Supported in part by the Bill & Melinda Gates Foundation, McElrath’s groundbreaking research generates new hope that a vaccine could end the epidemic not only in Africa but in her own back yard.

"The infection rate is on the rise in America within high-risk populations," she said. "AIDS is far from over in this country."

McElrath is also driven to conquer the disease on a personal level.

"As a parent, part of the reason I do this research is to create a brighter future for my son's generation," she said. "It makes my work that much more important to me."


Researcher News

All news
A promising HIV vaccine candidate gets a little help New strategy stirs a robust response from T cells tracked by McElrath lab May 24, 2023
Latest Fred Hutch research on COVID-19 How Hutch scientists have been tackling coronavirus in lab and clinic June 30, 2022
Test of a new 'germline-targeting' HIV vaccine prepares to launch Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus May 19, 2022
Tackling the unknowns of long-haul COVID-19 Fred Hutch and UW researchers are working together to better understand and treat the syndrome January 26, 2022